Skip to main content

Advertisement

SpringerLink
Log in

Could high plasma bikunin predict a favorable outcome in ovarian cancer?

  • Practice Point
  • Published:

From Nature Clinical Practice Oncology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mano A et al. (2005) CA-125 AUC as a new prognostic factor for patients with ovarian cancer. Gynecol Oncol 97: 529–534

    Article  CAS  PubMed  Google Scholar 

  2. Bast RC Jr et al. (2002) Early detection of ovarian cancer: promise and reality. Cancer Treat Res 107: 61–97

    PubMed  Google Scholar 

  3. Hellstrom I et al. (2003) The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res 63: 3695–3700

    PubMed  Google Scholar 

  4. McIntosh MW et al. (2004) Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma. Gynecol Oncol 95: 9–15

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Shridhar V et al. (2001) Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res 61: 5895–5904

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Associate Member at the Fred Hutchinson Cancer Research Center and Principal Investigator of the Computational Proteomics Laboratory, Seattle, WA, USA

    Martin McIntosh

Authors
  1. Martin McIntosh
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McIntosh, M. Could high plasma bikunin predict a favorable outcome in ovarian cancer?. Nat Rev Clin Oncol 2, 502–503 (2005). https://doi.org/10.1038/ncponc0315

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0315

  • Springer Nature Limited

This article is cited by

Search

Navigation